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ABSTRACT 
BACKGROUND:  
Cell proliferation rate is one of the important determinants of prognosis in 
cancer. Oral cancer prognosis differs among different subsites and it is also influenced 
by the etiological factors. 
AIM AND OBJECTIVE: 
To compare the cell proliferative index and to evaluate the role of causative factors 
among different sub sites of patients with oral squamous cell carcinoma by assessing  the cell 
proliferation by mean AgNOR counts. 
MATERIALS AND METHODS: 
This is a prospective study and a total of 94 subjects with histologically 
proven oral squamous cell carcinoma were included. They were classified into four 
groups based on the site of the lesion, namely, carcinoma of buccal mucosa (group I), 
carcinoma of alveolar mucosa (group II), carcinoma of tongue (group III), carcinoma 
of retromolar trigone area (group IV). Each group was inturn subdivided into sub-
groups based on the etiological factors. The etiological factors considered in our study 
were betel quid chewing, mawa or gutka chewing and smoking for group I, group II 
and group IV and trauma was considered to be an etiological factor for group III. The 
cell proliferation marker used in this study are the silver-stained nucleolar organizer 
regions (AgNORs) and mean AgNOR count was used to compare the cell 
proliferation rate among the four groups and amongst the sub-groups in each group. 
The results were analysed for statistical significance. 
RESULTS: 
 The mean AgNOR count for group III (carcinoma of tongue) was significantly 
higher than the other groups. Amongst the sub-groups of group I (carcinoma of buccal 
mucosa), sub-group with etiology of smoking showed significantly higher mean 
AgNOR counts. In case of group III (carcinoma of tongue) sub-group with trauma as 
the etiological factor showed significantly higher mean AgNOR counts than sub-
groups with other etiological factors 
CONCLUSION: 
 Carcinoma of tongue showed greater cell proliferation rate when compared to 
other subsites of oral cavity considered in this study. Thus greater cell proliferation 
rate could be one of the reasons for poor prognosis of tongue cancer as established by 
many other studies. Trauma causes greater cell proliferation rate when compared to 
other etiological factors in tongue. In buccal mucosa, smoking causes greater cell 
proliferation when compared to other etiologies. Further studies are required to 
establish the influence of the site of origin and different etiological factors on cell 
proliferation rate and hence the prognosis of oral squamous cell carcinomas. 
 
 Key words: Cell proliferation, Oral cancer sub-sites, AgNORs,  
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INTRODUCTION 
The squamous cell carcinoma is the most common malignant neoplasm of the 
oral cavity accounting to about 85% of the total oral malignant neoplasms.
1 
Oral 
squamous cell carcinoma (OSCC) is the eighth most common cancer worldwide, but 
the incidence is higher in developing countries when compared to developed 
countries. The age-standardised mortality rate due to oral cancer in India is greater 
than 3.0 per 100,000 populations which is very high compared to other areas.
2 
 
The prognosis of oral squamous cell carcinoma depends on multiple factors, of 
which cell proliferation is one of the most important factors.
3,4
 The proliferative 
activity of the cell depends on the cell cycle which  is  inversely proportional to the 
speed of the cell cycle or the generation time, and directly proportional to the 
proportion of cells committed to enter the cell cycle or the growth fraction.
4 
However, 
unlike the normal cells, proliferation of neoplastic cells occurs in the absence of 
corresponding increase in the epithelial cell loss.
5 
 
The proliferative activity can be assessed by cell proliferation markers, which 
are classifiable as growth fraction markers, markers of specific phases of cell cycle 
and cell cycle time markers.
 
The growth fraction can be determined by MIB1 or Ki-67 
antibodies which identify the antigen expressed in non-mitotic phases (G1, S and G2) 
of the cell cycle.
6 
The mitotic phase can be evaluated by counting the mitotic figures 
which is an oldest and popular way of assessing the cell proliferation.
7 
The S phase 
fraction can be assessed by incorporation techniques which use titrated thymidine 
(TH3) or bromodeoxyuridine and by immunohistochemical assessment for 
proliferating cell nuclear antigen (PCNA), a nuclear protein involved in DNA 
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synthesis or cyclins.
6
 The percentage of cells in various phases of cell cycle can also 
be determined by flow cytometry.
8 
 
The cell cycle time can be evaluated by simpler procedures like quantification 
of the argyrophilic proteins associated with the nucleolar organizer regions 
(AgNORs).
8
 AgNOR techniques mark the proteins associated to the nucleolar 
organizer regions (NORs). NORs are loops of DNA that transcribe for ribosomal 
RNA. They are located on the short arm of chromosomes 13, 14, 15, 21, and 22. 
There are certain acidic and argyrophilic, nonhistonic proteins called NOR-associated 
protein codes in these regions. NORs can be demonstrated in tissue sections by 
staining their associated proteins with colloidal silver and these silver stained reaction 
products represent the AgNOR.
9
 According to Sirri et al, 2000,
10
 the higher the 
number of NORs, the lower is the duration of the cell cycle and the higher the rate of 
cell proliferation. Therefore, the quantative analysis of AgNOR is an excellent 
indicator of cell proliferation that may predict the prognosis of tumors.
9,10,11 
Also, 
AgNOR is cheaper, reliable and less time consuming when compared to other 
methods
11
 and the results obtained are comparable with other methods.
12 
Smoking amounts to about 42% of death due to oral cancer worldwide. 
However in India and its neighbouring countries use of various forms of smokeless 
tobacco and betel quid with or without tobacco are the major risk factors.
13
 In the 
population under study, smoking, use of smokeless tobacco in the form of maawa, 
gutka and snuff dipping, betel quid chewing and trauma were found to be the common 
etiological factors. But each of these causative factors has been known to 
differentially influence the cell proliferation rates in the oral mucosa.
14,15,16
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Although the prognosis of OSCC differs among sites within the oral 
mucosa,
17,18 
it is not clear whether the cell proliferation is in itself a prognostic 
determinant, especially among different subsites when exposed to different causative 
factors. 
 
The purpose of this study is to compare the cell proliferative index and to 
evaluate the roles of causative factors among subsites within the oral cavity of 
patients with oral squamous cell carcinoma by assessing the cell proliferation by 
(mean) AgNOR counts. 
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AIM 
To compare the cell proliferative index and to evaluate the role of causative 
factors among different sub sites of patients with oral squamous cell carcinoma. 
OBJECTIVE 
 To assess the cell proliferation by mean AgNOR counts in oral squamous cell 
carcinoma. 
 
 
5 
 
REVIEW OF LITERATURE 
CELL PROLIFERATION AND CANCER 
 Pardee AB et al,
19
 in 1989 suggested that cells that enter G1 phase are the 
main determinants of the cell proliferation rate and are defectively controlled in 
cancer cells.  
Ames BN et al,
20
 in 1990 attempted to clarify the mechanism of 
carcinogenesis. In their perspective they have stated that a dividing cell is much more 
at risk of mutating than a resting  cell and many stable mutations can occur during cell 
division due to endogenous mutagens which form oxidative products which inturn 
causes massive damage to DNA. This oxidative damage is the major contributor to 
degenerative changes leading to cancer. Thus any agent causing chronic mitogenesis 
is mutagenic and they concluded that mitogenesis increases mutagenesis. 
Cohen SM et al,
21
in 1990 illustrated the critical role of cell proliferation in 
carcinogenesis using two protypical compounds, a genotoxic carcinogen 2-
acetylaminofluorene (2-AAF), and a nongenotoxic agent, sodium saccharin. They 
suggested that the carcinogenic dose-response relationship for these genotoxic 
chemicals was also due in part to increased cell proliferation. Mechanistic information 
is required for determination of the existence of a threshold for the proliferative (and 
carcinogenic) response of nongenotoxic chemicals and the estimation of risk for 
human exposure. 
Weinstein IB
22
 in 1991 contradicted the the theory that that mitogenesis is the 
major rate-limiting factor in carcinogenesis requires that cell replication per se be 
highly hazardous because of the inherent danger of spontaneous mutations. He 
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believed that cell replication is one of the roles (but not the only role) of carcinogenic 
agents 
 Croy RG
23
 in 1993 examined the current understanding of the mechanisms by 
which chemicals provoke cell proliferation and the contribution of various kinetic 
patterns of cell proliferation to carcinogenesis. In this review, he insisted that cell 
division plays a key role at each stage in the evolution of cancer, and it is well 
documented that increased rates of cell proliferation can escalate the risk of 
malignancy. 
Thompson PJ et al,
24
 in 2002 studied the relationship between epithelial cell 
proliferative activity and oral cancer progression. Archival tissue specimens from 10 
previously treated patients with oral cancer with 3-years follow up were evaluated for 
cell proliferation markers like Ki67, cyclin A and histone mRNA cell cycle markers. 
While histone mRNA labelling ultimately proved unreliable, both Ki67 and cyclin A 
labeling indices demonstrated an enhanced labelling to occur in increasingly 
dysplastic and neoplastic tissue. They also showed increase ki67 and cyclin A 
labeling indices and suprabasal labeling in patients who developed recurrence of the 
lesion or lymph node involvement thus indicating poor prognosis. Thus the 
measurement of cell proliferative activity in individual oral epithelial dysplastic 
lesions or invasive squamous cell carcinomas can provide predictive information on 
clinical outcome. 
Preston-Martin et al
16
 in 1990, dicussed examples of human cancer in which 
increased cell division leads to neoplastic transformation due to accumulation of 
genetic defects. He had discussed about many risk factors causing cell proliferation 
pertaining to the site of the lesion. He had discussed tobacco as one of the chemical 
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agents causing increased cell proliferation in the oral cavity. He also added that all 
quids that are usually held in buccal mucosa are a source of mechanical trauma and 
those that contain salked lime have a caustic effect which in turn increases cell 
proliferation to replace lost cells. 
CELL PROLIFERATION MARKERS 
van Diest PJ et al,
4
 in 1998 in his review aimed  to provide an overview of 
methods currently available for assessment of proliferation, and to discuss critically 
their cell biological framework, their methodology, and some of the most important 
applications of these methods. He had described the following methods of assessment 
of cell proliferation which includes, incorporation techniques using incorporation of 
labelled nucleotide analogues, such as tritiated thymidine or bromodeoxyuridine 
(BrdU)., counting of mitotic figures, DNA cytometric analysis of percentage of cells 
in S phase of cell cycle, immunohistochemical analysis of proliferation associated 
antigens like PCNA, Ki67, MIB-1 and  assessment of AgNORs. 
Iatropoulos MJ et al,
25
 in 1996 discussed the proliferation markers and 
tabulated the six commonly used proliferation markers which included  PCNA, p53, 
Ki67, AgNORs, statins and thymidine analogues. He also compared PCNA and BrdU 
markers from 3 tissues, i.e. liver, glandular stomach, and uterus, across 2 or 3 strains 
of rats. He concluded that that PCNA is the most reliable and versatile of all markers 
used, capable of rendering good results even from archival specimens. 
Liu SC et al,
26
 in 2000 have reviewed the recent literature on 
immunohistochemical markers of cell proliferation in normal oral epithelia and 
leukoplakias. Most findings, pointed to an increased proliferation in oral leukoplakias 
that correlates with the degree of dysplasia. These changes were detected with several 
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markers including PCNA, Ki-67 (Mib-1), cyclin D1 and CENP-F as well as with 
procedures using pulse labeling with BrDU, IrDU and tritiated thymidine. 
Comparison of all methods showed more similarities than discrepancies.  
Lindboe CF et al,
7
 in 2002 compared the Ki67 equivalent antibodies with 
regard to qualitative and quantitative immunohistochemical staining characteristics. 
He compared the staining characteristics of monoclonal MIB-1, monoclonal MM1, 
polyclonal NCL-Ki-67p, polyclonal Rah Ki-67. The MIB-1 antibody appears to have 
a higher sensitivity for detecting the Ki-67 antigen than the other three tested 
antibodies. 
Dissanayake U et al,
27
 in 2003 studied the cell proliferation stautus in oral 
squamous cell carcinomas by comparing the cell proliferation rate using Ki67 index in 
the centre and advancing front of the tumour. The Ki67 index was significantly higher 
in the advancing front when compared to the centre of the tumor which indicates that 
the cells in the invasive front are more proliferating and hence they suggested that it is 
likely to be more informative in cell cycle studies and in studies involving cell 
proliferation as prognostic indicator. 
 
The AgNORs 
The nucleoli usually disappear during the mitotic phase of cell division. 
However, at the end of telophase and in interphase they reform round weakly stained 
chromatin regions which correspond to secondary constrictions of metaphase 
chromosomes of eukaryotic cells. These regions are called as the nucleolar organizer 
regions (NORs) and they contain genes that code for ribosomal RNA. The nucleolar 
organizer regions (NORs) were first described by Heitz in 1931.
9
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Goodpasture C and Bloom SE
28
 in 1975 attempted to visualize NORs in 
mammalian chromosomes using silver staining and in-situ hybridization and 
described silver-stained NORs as Ag-NORs which appeared  as black-spherical 
bodies on yellow-brown chromosomal arms. These represent the  chromosomal 
locations  of genes coding for  18S-28S ribosomal  RNA. They also suggested that 
there are various chromosomal proteins associated with NORs called NOR specific 
proteins which indeed take up the silver stain rather than rRNA itself. These 
argyrophilic proteins were found to be protein C23 nucleolin and protein B23.
10 
Miller OJ et al
29
 in 1976 localized nucleolar organizer activity to 
chromosomes 13, 14, 15, 21(rarely) and 22 in humans by silver-staining method.  
 Crocker J et al
30
 in 1989 suggested that AgNORs may present in the 
following three types of configuration in normal and neoplastic cells. In the first type, 
the NORs are fully aggregated to form a single rounded dark staining structure with 
no subdots which corresponds to the nucleolus. This type is commonly seen in resting 
lymphocytes and quiescent cells. In the seond type, the subsidiary dots can be 
visualized inside the nucleolus. This type is seen commonly in proliferating cells. The 
third type comprises of small "true" AgNORs scattered throughout the nucleoplasm 
which are frequently observed in highly malignant cells. All these features were very 
evident in cytological sections and carefully prepared paraffin sections. 
REVIEW ON AgNOR STAINING AND QUANTITATION 
 Bloom SE and Good Pasture C
31 
in 1976 demonstrated a simplified and 
standardized technique for staining of nucleolar organizer regions in human 
chromosomes. It was based on ammonical silver nitrate technique by Howell et al, 
1975. 
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Trere D
32
 in 2000 critically evaluated various methods that were commonly 
employed to stain AgNORs in cytopathology and histopathology. He has 
comprehensively described various methods for AgNOR staining  which included 
Ploton’s one-step staining procedure (1989) where the staining was performed at 
lower temperature when compared the the original method of staining by Howell. He 
has also described in detail a standardized method proposed by Aubele et al in 1994 in 
International committeefor AgNOR quantitation, in which they had proposed different 
staining methods for cytological smears, frozen sections and histological samples 
fixed in ethanol and formalin. Although the committee had recommended the use of 
image analysis for counting purpose 84.6% of papers published since 1987 used 
routine counting method only.  
Crocker J et al,
30
 in 1989 proposed a standardized method for counting 
AgNORs. He proposed a method in which first all the silver stained structures are 
counted, but when lying in groups each cluster is treated as one structure. Then, 
whereAgNORs can be visualized in the nucleolus, each AgNOR should be counted as 
a unit together with smaller AgNORs seen outside the nucleolus. However in resting 
cells it is not possible to resolve separate AgNORs within the nucleoli where they are 
wholly aggregated. So they suggested that in order to get total AgNOR count both 
extra-nuclear and intra-nuclear dots should be enumerated.  
Derenzini M et al,
33
 in 1991 attempted to standardize interphase AgNOR 
measurement by means of automated image analysis system and used lymphocytes as 
internal control for the standardization procedure. He also discovered that AgNOR 
area was influenced by the fixatives used and also the staining time. 
Bukhari MH et al,
34
 2007 proposed a modified method of AgNOR counting 
in which they reduced the staining time and used 10% sodium thiosulphate and 1% 
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gold chloride solution as toning solution. Gold chloride produced better clarity when 
compared to sodium thiosulphate. They also added that the use of counterstain like 
neutral red interfered with staining quality and hence did not recommend it. . 
 
SIGNIFICANCE OF AgNOR AS CELL PROLIFERATION MARKER 
Trere D et al,
35
 in 1989 studied the relationship between interphasic silver-
stained proteins of the nucleolar organizer regions (Ag-NOR proteins) and cell 
replication rate in 13 established neuroblastoma cell lines and used automated image 
analyser to measure the quantity of Ag-NOR proteins. The results indicated that the 
amount of Ag-NOR proteins is strictly proportional to the proliferative activity of the 
cells and hence they suggested its use as a parameter for determining the cell 
proliferation rate. 
Sirri V et al,
10
 in 2000 determined the variation of expression of AgNOR 
proteins in different  phases of cell cycle. They quantified the AgNOR proteins in 
different phases of cell cycle using electrophoresis and western blot analysis. They 
determined that the amount of AgNOR proteins increased during S-G1 phase and 
higher the amount of AgNOR proteins signifies greater number of cells in S-G1 phase 
of cell cycle. Thus AgNORs can be reliably used as cell proliferation markers. 
Costa ALL et al,
12
 in 1999 compared the effectiveness of AgNOR staining 
with other proliferative markers like Ki67, PCNA using double-staining technique. 
The slides were first stained for PCNA and Ki67 immunohistochemical markers 
separately and then the sections were overstained for AgNOR. They found that there 
was positive correlation between presence of AgNORs and cells that have taken up 
PCNA or Ki67 staining. Thus AgNOR is an equally effective marker when compared 
to PCNA or Ki67. 
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AgNORs IN ORAL SQUAMOUS CELL CARCINOMA 
Xie X et al,
36
 in 1997 evaluated the AgNOR counts in normal epithelium, 
dysplastic epithelium and squamous cell carcinoma of oral cavity. They also tested 
the AgNOR counts for prognostic significance using clinical parameters. The mean 
AgNOR counts were significantly higher in squamous cell carcinoma when compared 
to normal and dysplastic epithelium. Also, logistic rank test revealed cases with mean 
AgNOR counts greater than 6.2 showed significantly greater recurrence rate. Also 
greater the percentage of nuclei with more than one AgNORs greater was the 
tendency for recurrence. 
Pillai KR et al,
11
 in 2005
 
analysed the prognostic significance of AgNORs in 
oral carcinomas. They concluded that mean AgNOR count greater than 2.8 concurred 
with poor prognosis in both univariate and multivariate analysis. Along with AgNOR 
counts, the T-status of disease was also found to be an independent predictor for 
treatment outcome in multivariate analysis. Thus T3 and T4 tumours, with mean 
AgNOR counts more than 2.8, were deemed to be aggressive and may exhibit 
resistance to current treatment protocols. 
Ashraf MJ et al,
37
 in 2010 studied the mean AgNOR counts, proliferative 
index and graded the variation in size and dispersion of AgNOR dots in cells in 
normal, dysplastic, primary and metastatic squamous cell carcinoma. The Ki67 
percentage is significantly increased from normal squamous to SCC group, and the 
reactivity of staining were related to histological differentiation. The mAgNOR 
counts were high in all the cases of primary and metastatic SCC and low in normal 
squamous tissue and increased in dysplastic lesions. 
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Chandak AR et al,
38
 in 2011 examined the possible association between 
epithelial proliferation and disease progression in the oral mucosa using the actual 
proliferation index which is measured by the product of Ki67 score and quantity of 
AgNOR. There was a significant correlation of Bryne’s histological malignancy 
grading with the argyrophilic nucleolar organizer region count and the Ki-67 labeling 
index. The actual proliferation index is not only useful as a prognostic factor, but 
could also be a promising treatment determining modality for patients with 
premalignant and malignant lesions. 
 Mekhri S et al,
39
 in 2010 carried out a study to analyze the distribution of the 
AgNOR in oral leukoplakia and oral squamous cell carcinoma, and in their various 
histological grades, and to assess if the AgNOR distribution could give information 
on the malignant potentiality in premalignant lesions and aggressiveness of the 
malignant lesions. The mean AgNOR count was higher in cases of oral squamous cell 
carcinoma when compared to cases of oral leukoplakia, and the AgNOR counts 
increased with the increase in the grades of dysplasia indicating a higher proliferative 
rate with increase in dysplasia 
 
SIGNIFICANCE OF ETIOLOGICAL FACTORS IN ORAL CANCER 
Kaur J et al,
40
 in 1994 studied the expression of p53 tumor-suppresor gene (a 
commonly identified mutated gene in diverse types of human cancer and plays an 
important role in regulation of normal cell proliferation) in normal mucosa, 
premalignant lesions and oral squamous cell carcinoma from Indian patients who 
consumed betel, areca nut and/or tobacco. There was higher frequency of p53 
overexpression in premalignant and malignant lesions in patients who were heavy 
consumers of betel, areca nut and tobacco 
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 Lewin F et al,
41
 in 1998 conducted a study to identify the possible factors 
involved in etiology of cancer of head and neck among men in two different 
geographical location in Sweden. The effects of tobacco smoking, oral snuff and 
alcohol were investigated.  They concluded that there was a dose dependent excess 
risk of cancer of the head and neck from tobacco smoking whereas there was no 
significant increase in relative risk for the use of Swedish oral snuff. In case of 
alcohol, moderate alcohol consumption showed no increase risk among ex-smokers or 
non-smokers, but an increased risk for oral cancer among current smokers. 
.Znaor et al,
42
 in 2003 assessed the independent and combined effects of 
different patterns of smoking, betel quid chewing and alcohol drinking in oral, 
pharyngeal and esophageal cancers. Betel quid chewers with or without tobacco 
showed the highest risk for cancer in other sites of oral cavity than tongue, pharynx 
and esophagus. Whereas, smoking showed lesser risk for cancer in oral cavity when 
compared to pharynx and esophagus. 
Fontes PC et al,
43
 in 2008 compared the AgNOR counts in exfoliative 
cytology of non-lesional tongue between smokers and non-smokers. The results 
showed significantly greater AgNOR counts in lateral border of tongue in smokers 
when compared to non-smokers. Thus smoking causes greater cell proliferation in 
lateral border of tongue even in the absence of clinically discernable lesion 
Lin WJ et al,
44
 in 2011 conducted a prospective study to investigate the 
association between oral cancer and etiological factors like smoking, alcohol 
consumption and betel quid chewing. The study group comprised of patients with oral 
cancer and the control group comprised of patients without oral cancer. A multivariate 
logistic regression model for exploring relevant risk factors for oral cancer was 
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created. The odds ratio was higher for betel quid chewers when compared to smokers 
and there was no significant risk for only alcohol consumers.  
Nair U et al,
45
 in 2004 postulated the mechanism of carcinogenesis and 
genotoxicity by more prevalent betel quid substitutes namely gutka and pan masala. 
Gutka consists of  flavoured and sweetened dry mixture of areca nut, catechu and 
slaked lime with tobacco. It has been implicated as a cause of oral sub-mucous 
fibrosis in young patients which ultimately has greater potential for malignant 
transformation. In this review they also added that mawa, which is similar to gutka in 
composition has been linked to oral submucous fibrosis, oral and esophageal cancer. 
Gupta PC et al,
46
 in 1998 conducted a survey in Bhavnagar district in Gujarat 
for assessing the use of various tobacco products and prevalence of oral submucous 
fibrosis. They found that areca nut was mostly used in form of mawa, a mixture of 
tobacco, lime and areca nut and mawa chewers showed high relative risk for oral 
submucous fibrosis and hence they suggested an increase in incidence of oral cancer 
among  maawa chewers in future 
Rahman M et al,
47
 in 2005 calculated the population attributable risk for bidi 
smoking and oral cancer in south Asia. They analysed twelve case-control studies 
conducted in India, Pakistan and Srilanka. Pooled odds ratio suggested that beedi 
smoking showed significant association with oral cancer cases in south Asia. 
 
PROGNOSIS OF ORAL SQUAMOUS CELL CARCINOMA OF DIFFERENT 
SUBSITES 
Garzino-Demo P et al,
17
 in 2006 analysed the outcome of patients undergoing 
treatment for oral squamous cell carcinoma in an attempt to identify the prognostic 
value of several clinicopathological parameters. There was significant difference in 
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the survival rate depending on the site of origin. Carcinoma of tongue showed lesser 
three year and five year survival rate when compared to carcinoma of gingival, buccal 
mucosa, buccal- retomolar trigone and floor of the mouth. 
 Rusthoven K et al in 2008
18
 compared the over all survival and cause specific 
survival in patients with squamous cell carcinoma of tongue and with other subsites.  
The five year over all survival and cause specific survival rate was lesser for oral 
squamous cell carcinoma of tongue compared to other subsites. Thus carcinoma of 
tongue showed poorer prognosis than carcinoma of other subsites of the oral cavity.  
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MATERIALS AND METHODS 
SOURCE & SELECTION OF CASES: 
  Out-Patient Department, 
 Department of Oral Pathology and Microbiology, 
 Tamil Nadu Government Dental College & Hospital, Chennai. 
Patients with histologically proven oral squamous cell carcinoma and their 
respective paraffin tissue wax blocks has been utilized for the study from the period of 
January 2012 to July 2012.  
STUDY GROUPS: 
Grouping based on site of biopsy. 
Group 1: Carcinoma of buccal mucosa 
Group 2: Carcinoma of Tongue 
Group 3: Carcinoma of Alveolar mucosa 
Group 4: Carcinoma of Buccal sulcus-Retromolar trigone area 
As this is a prospective study, the number of cases in each group varied. 
Minimum number of cases for each group : 10 
SELECTION CRITERIA 
Inclusion criteria: 
Group 1: BUCCAL MUCOSA 
Group 2: TONGUE 
1. Should have histologically proven squamous cell carcinoma  
2. Patients with known history of maawa/gutka chewing, beetel quid chewing, 
smoking, trauma. 
Group 3: ALVEOLUS 
__________________________________________________________________Materials and Methods 
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Group 4: RETROMOLAR TRIGONE-BUCCAL SULCUS AREA 
 Same as above except H/o trauma which is relatively uncommon in these 
areas. 
Exclusion criteria: 
Clinical exclusion criteria: 
• Patients with clinical diagnosis of oral squamous cell carcinoma but not 
proven histopathologically  
• Patients having more than one etiology included in each group.  
• Patients with etiologies other than the above mentioned ones. 
• Patients with history of maawa/gutka, betel quid chewing and smoking for a 
period of less than 6 months. 
• Premalignant lesions or conditions 
Histological exclusion criteria: 
 No evidence of invasive squamous cell component in the given section 
 Loss of tissue while sectioning 
METHODOLOGY: 
1. Following selection of subjects based on inclusion and exclusion criteria, written 
informed consent (Appendix 1 & 2), which was approved by the Institute’s Ethical 
Committee, was obtained from all the subjects selected for the study after 
explaining the study procedure. 
2. H/O trauma and habits related to oral squamous cell carcinoma were recorded for 
the patients with histologically proven oral squamous cell carcinoma reporting to 
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the Department of Oral Pathology while the patients come to collect the biopsy 
report. 
3. The paraffin blocks of the corresponding patients were retrieved from the 
Department archives and 4µm thick tissue sections are to be made using 
microtome. 
4. A total of 94 cases were included in our study based on clinical and histological 
inclusion and exclusion criteria. There were no cases with history of trauma in 
group I (carcinoma of buccal mucosa) and no cases with history of betel quid 
chewing in group III (carcinoma of tongue). 
 5. Staining for AgNORs: 
Modified AgNOR staining method as proposed by Bukhari et al,
34
  2007.
 
The tissue is deparaffinized in several changes of xylene and descending 
alcohol concentrations. Rehydration is then performed in several changes of ultrapure 
distilled water. The tissue is then incubated in acid alcohol (three parts ethanol: two 
parts acetic acid) for 5 min and then rinsed in ultra pure distilled water several times.  
Solution A (2% concentration) 
Gelatin powder    500mg 
Formic acid          250µl 
Deionized water   25ml 
Solution B (50% concentration) 
Silver nitrate         30 g  
Deionized water    60 ml 
Working solution : to be prepared just before use 
Solution A  1 part 
Solution B  2 parts 
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Toning solution 
Sodium thiosulphate 10% 
Gold chloride 1% 
 The prepared solutions were stored in polypropylene containers, so as to avoid 
leaching of cations like sodium from glass containers into the reagents. These cations 
result in background silver deposition. 
Staining procedure: 
The pretreated sections are incubated with silver nitrate solution (working 
solution) in a dark humidified chamber for 38 min at room temperature 37 °C. The 
sections are then incubated in 10% sodium thiosulphate or 1% gold chloride solution 
for 5 minutes.  The sections are then washed in distilled water, dehydrated in graded 
alcohol and then xylene and mounted. 
6. AgNOR counting : 
• The nuclei stain light yellow and outline of nuclei as well as cells were usually 
clearly visible. 
• The AgNORs are visualized as brown black discrete dots of variable size 
within the nuclei.  
• In each section 100 cells were counted. Two to five fields were evaluated in 
each section. The first field of vision was subjectively chosen. Subsequent 
fields were systematically selected roughly proportional to the overall size of 
the tumor area.  
• Areas with necrosis, pronounced inflammation, artificial damage, or 
pronounced keratinization were disregarded. In each field the counting started 
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in the upper left square, moving downward. Careful focusing was used to 
visualize all AgNORs within each nucleus. 
48
 
• The lymphocytes and normal adjacent non dysplastic epithelia were used as 
internal control for staining.
33
  
• The number of AgNORs in 100 tumor cell nuclei is counted and average is 
taken as mean AgNOR count (mAgNOR). 
• AgNOR counting was performed under 1000x (100x objective x 10x 
eyepiece)  using oil immersion according to criteria proposed by Crocker J et 
al. 1989.
30
 
• Firstly, all silver stained structures should be counted, but when lying in 
groups each cluster (almost aggregated or partly disaggregated nucleoli) 
treated as one structure. 
• Secondly, where AgNORs can be seen separately within a nucleolus, each 
AgNOR should be counted as a unit, together with the smaller AgNORs seen 
outside the nucleolus. 
7. Statistical analysis: 
a. The mean mAgNOR counts are calculated for each study group and 
compared. 
b. The mean mAgNOR counts are calculated for different etiologies for each 
group of patients and compared. 
c. The mean mAgNOR counts for common etiologies for all four subgroups 
are calculated according to the subsites involved and compared. 
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The collected data was analysed with SPSS 16.0 version. To describe about 
the data descriptive statistics mean, S.D were used. For the multivariate analysis the 
one way analysis of variance (ANOVA) with Post-hoc test Tukey's HSD was used to 
find the significance difference between the inter group comparison . In all the above 
statistical tools the probability value P=0.05 is considered as significant level.  
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Table 1. MASTER CHART FOR GROUP I 
 
SNo HP No. ETIOLOGY 
1. 14150 Betel quid chewing 
2. 14312 Betel quid chewing 
3. 14318 Betel quid chewing 
4. 14327 Betel quid chewing 
5. 14350 Betel quid chewing 
6. 14473 Betel quid chewing 
7. 14501 Betel quid chewing 
8. 14700 Betel quid chewing 
9. 14248 Maawa/gutka chewing 
10. 14250 Maawa/gutka chewing 
11. 14257 Maawa/gutka chewing 
12. 14302 Maawa/gutka chewing 
13. 14336 Maawa/gutka chewing 
14. 14399 Maawa/gutka chewing 
15. 14556 Maawa/gutka chewing 
16. 14633 Maawa/gutka chewing 
17. 14639 Maawa/gutka chewing 
18.  14662 Maawa/gutka chewing 
19. 14680 Maawa/gutka chewing 
20. 14687 Maawa/gutka chewing 
21. 14697 Maawa/gutka chewing 
22. 14708 Maawa/gutka chewing 
23. 14711 Maawa/gutka chewing 
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24. 14551 Smoking 
25. 14615 Smoking 
26. 14641 Smoking 
27. 14676 Smoking 
28. 14677 Smoking 
29. 14690 Smoking 
30. 14727 Smoking 
 
SUB-GROUP I A : Etiology of betel quid chewing 
SUB-GROUP I B : Etiology of maawa or gutka chewing 
SUB-GROUP I C : Etiology of smoking 
 
 
Table 2. MASTER CHART FOR GROUP II 
 
SNo HP No ETIOLOGY 
1. 14300 Betel quid chewing 
2. 14329 Betel quid chewing 
3. 14371 Betel quid chewing 
4. 14439 Betel quid chewing 
5. 14444 Betel quid chewing 
6. 14458 Betel quid chewing 
7. 14470 Betel quid chewing 
8. 14472 Betel quid chewing 
9. 14507 Betel quid chewing 
10. 14522 Betel quid chewing 
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11. 14572 Betel quid chewing 
12. 14630 Betel quid chewing 
13. 14723 Betel quid chewing 
14. 14384 Maawa/gutka chewing 
15. 14560 Maawa/gutka chewing 
16. 14561 Maawa/gutka chewing 
17. 14591 Maawa/gutka chewing 
18. 14628 Maawa/gutka chewing 
19. 14675 Maawa/gutka chewing 
20.  14383 Smoking 
21. 14440 Smoking 
22. 14559 Smoking 
23. 14597 Smoking 
24. 14603 Smoking 
 
SUB-GROUP IIA : Etiology of Betel quid chewing habit 
SUB-GROUP IIB : Etiology of maawa/gutka chewing habit 
SUB-GROUP IIC : Etiology of smoking 
 
Table 3. MASTER CHART FOR GROUP III 
 
SNo HP No ETIOLOGY 
1. 14265 Maawa/gutka chewing 
2. 14359 Maawa/gutka chewing 
3. 14421 Maawa/gutka chewing 
4. 14477 Maawa/gutka chewing 
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5. 14645 Maawa/gutka chewing 
6. 14671 Maawa/gutka chewing 
7. 14692 Maawa/gutka chewing 
8. 14726 Maawa/gutka chewing 
9. 14151 Trauma 
10. 14347 Trauma 
11. 14386 Trauma 
12. 14468 Trauma 
13. 14521 Trauma 
14. 14528 Trauma 
15. 14598 Trauma 
16. 14606 Trauma 
17. 14622 Trauma 
18. 14661 Trauma 
19. 14669 Trauma 
20. 14702 Trauma 
21.  14736 Trauma 
22. 14398 Smoking 
23. 14410 Smoking 
24. 14704 Smoking 
25. 14707 Smoking 
 
SUB-GROUP IIIA : Etiology of maawa/gutka chewing 
SUB-GROUP IIIB : Etiology of trauma 
SUB-GROUP IIIC : Etiology of smoking 
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Table 4. MASTER CHART FOR GROUP IV 
 
SNo HP No ETIOLOGY 
1. 14375 Betel quid chewing 
2. 14497 Betel quid chewing 
3. 14523 Betel quid chewing 
4. 14636 Betel quid chewing 
5. 14667 Betel quid chewing 
6. 14280 Maawa/gutka chewing 
7. 14288 Maawa/gutka chewing 
8. 14328 Maawa/gutka chewing 
9. 14395 Maawa/gutka chewing 
10. 14460 Maawa/gutka chewing 
11. 14461 Maawa/gutka chewing 
12. 14563 Maawa/gutka chewing 
13. 14706 Maawa/gutka chewing 
14. 14441 Smoking 
15. 14446 Smoking 
 
SUB-GROUP IVA : Etiology of Betel quid chewing 
SUB-GROUP IVB : Etiology of Maawa/gutka chewing 
SUB-GROUP IVC : Etiology of smoking 
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Fig 1. Staining kit 
 
 
 
 
 
Fig 2. Staining solutions 
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Fig 3. Other Armamentarium 
 
 
 
 
 
 
 
 
Fig 4. Microscope and Stained slides 
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Fig 5. AgNORs (x 400) 
 
 
 
 
 
Fig 6. AgNORs (x1000) (oil immersion) 
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Fig 7. AgNORs in lymphocytes (x 1000) (oil immersion) 
 
 
 
 
 
Fig 7. AgNORs in normal oral mucosa (x 400) 
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RESULTS 
In the present study, a total of 94 cases of histopathologically proven OSCC 
were included, among which 30 patients had OSCC of buccal mucosa (Group I), 24 
patients had OSCC of alveolar mucosa (Group II), 25 patients had OSCC of tongue, 
15 patients had OSCC of retromolar trigone area (Group IV) (table 1,2,3,4). Each 
group was further divided into sub-groups based on etiological factors. Sub-group IA 
included 8 cases of OSCC of buccal mucosa with habit of betel quid chewing, Sub-
group IB included 15 cases with etiology of mawa/gutka chewing, Sub-group IC 
included 7 cases with etiology of smoking (table 1). Group II had etiological factors 
similar to group I and was similarly subdivided into Sub-group IIA, IIB, IIC with 13, 
6, 5 cases in each Sub-group respectively (table 2). Group III did not have cases with 
etiology of betel quid chewing but included cases with etiology of trauma. It was 
hence sub-divided into Sub-group IIIA with etiology of mawa/gutka chewing, Sub-
group IIIB with etiology of trauma and Sub-group IIIC with etiology of smoking 
(table 3). Group IV was subdivided similar to group I and II (table 4).Table 1, 2, 3, 4 
represents the master chart for Group I, II, III, IV respectively.  
The histological sections from blocks retrieved from department archives for 
all these cases were stained for visualizing AgNORS and the mean AgNOR count was 
calculated for each caase and compared. 
The average mean AgNOR counts for Group I, Group II, Group III and Group 
IV were found to be 3.1883, 3.1350, 3.6724 and 3.1507 respectively. The mean 
AgNOR count for Group IV was significantly higher than Group I, II and III with P 
value = 0.001 (P<0.05). (table 9,10,11 and Fig 9) 
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In Group I, the average of mean AgNOR counts for each Sub-groups revealed 
a significantly higher value for Sub-group IC (mAgNOR=3.604) when compared to 
Sub-group IA (mAgNOR=2.9975) and Sub-group IB (mAgNOR=3.096) with P value 
less than 0.05.(table 12,13 and Fig 10) 
In Group II, there was no significant difference in the mean AgNOR counts 
among Sub-Group IIA, IIB, IIC with P value greater than 0.05.(table 14 and Fig 11) 
In Group III, Sub-group IIIB (mAgNOR=4.4138) showed significantly higher 
mean AgNOR counts when compared to Sub-group IIIA (mAgNOR=3.1375) and 
Sub-group IIIC (mAgNOR=3.2100) with P value 0.000. (P<0.05)(table 15,16 and Fig 
12) 
In Group IV, there was no significant difference in the mean AgNOR counts 
between the Sub-groups IVA, IVB, IVC and IVD. (P>0.05) (table 17 and Fig 13) 
When comparing the mean AgNOR counts between the Groups for etiology of 
betel quid chewing, i.e., Sub-group IA, IIA and IVA, there was no statistically 
significant difference(table 18).Similarly, when comparing the mean AgNOR counts 
between the groups for etiology of mawa/gutka chewing, i.e., Sub-group IB, IIA,IIIB, 
there was no statistically significant difference.(table 19) 
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Table 5 :  mAgNOR COUNTS IN GROUP I – Carcinoma of BUCCAL 
MUCOSA 
SNo HP No. ETIOLOGY mAgNOR count 
1. 14150 Betel quid chewing 2.55 
2. 14312 Betel quid chewing 3.87 
3. 14318 Betel quid chewing 3.64 
4. 14327 Betel quid chewing 2.55 
5. 14350 Betel quid chewing 2.84 
6. 14473 Betel quid chewing 2.92 
7. 14501 Betel quid chewing 2.67 
8. 14700 Betel quid chewing 2.94 
9. 14248 Maawa/gutka chewing 3.19 
10. 14250 Maawa/gutka chewing 2.42 
11. 14257 Maawa/gutka chewing 2.76 
12. 14302 Maawa/gutka chewing 3.39 
13. 14336 Maawa/gutka chewing 2.98 
14. 14399 Maawa/gutka chewing 2.83 
15. 14556 Maawa/gutka chewing 3.64 
16. 14633 Maawa/gutka chewing 2.96 
17. 14639 Maawa/gutka chewing 3.01 
18.  14662 Maawa/gutka chewing 3.28 
19. 14680 Maawa/gutka chewing 2.80 
20. 14687 Maawa/gutka chewing 3.28 
21. 14697 Maawa/gutka chewing 3.32 
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22. 14708 Maawa/gutka chewing 2.26 
23. 14711 Maawa/gutka chewing 4.32 
24. 14551 Smoking 3.64 
25. 14615 Smoking 3.65 
26. 14641 Smoking 3.63 
27. 14676 Smoking 3.68 
28. 14677 Smoking 3.66 
29. 14690 Smoking 3.32 
30. 14727 Smoking 3.65 
 
SUB- GROUP I A : Etiology of betel quid chewing 
SUB-GROUP I B : Etiology of maawa or gutka chewing 
SUB-GROUP I C : Etiology of smoking 
Table 6:  mAgNOR COUNTS IN GROUP II – Carcinoma of ALVEOLAR 
MUCOSA 
SNo HP No ETIOLOGY mAgNOR count 
1. 14300 Betel quid chewing 3.48 
2. 14329 Betel quid chewing 2.97 
3. 14371 Betel quid chewing 2.64 
4. 14439 Betel quid chewing 3.44 
5. 14444 Betel quid chewing 2.80 
6. 14458 Betel quid chewing 3.14 
7. 14470 Betel quid chewing 3.58 
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8. 14472 Betel quid chewing 2.41 
9. 14507 Betel quid chewing 2.22 
10. 14522 Betel quid chewing 3.48 
11. 14572 Betel quid chewing 2.70 
12. 14630 Betel quid chewing 2.65 
13. 14723 Betel quid chewing 2.92 
14. 14384 Maawa/gutka chewing 3.34 
15. 14560 Maawa/gutka chewing 3.75 
16. 14561 Maawa/gutka chewing 3.12 
17. 14591 Maawa/gutka chewing 3.33 
18. 14628 Maawa/gutka chewing 3.43 
19. 14675 Maawa/gutka chewing 3.30 
20.  14383 Smoking 3.59 
21. 14440 Smoking 3.64 
22. 14559 Smoking 3.28 
23. 14597 Smoking 3.28 
24. 14603 Smoking 2.75 
 
SUB-GROUP IIA : Etiology of Betel quid chewing habit 
SUB-GROUP IIB : Etiology of maawa/gutka chewing habit 
SUB-GROUP IIC : Etiology of smoking 
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Table 7: mAgNOR COUNTS IN GROUP III – Carcinoma of TONGUE 
SNo HP No ETIOLOGY mAgNOR count 
1. 14265 Maawa/gutka chewing 2.58 
2. 14359 Maawa/gutka chewing 3.86 
3. 14421 Maawa/gutka chewing 3.22 
4. 14477 Maawa/gutka chewing 3.30 
5. 14645 Maawa/gutka chewing 3.32 
6. 14671 Maawa/gutka chewing 2.80 
7. 14692 Maawa/gutka chewing 3.28 
8. 14726 Maawa/gutka chewing 2.74 
9. 14151 Trauma 4.34 
10. 14347 Trauma 4.03 
11. 14386 Trauma 4.28 
12. 14468 Trauma 3.88 
13. 14521 Trauma 4.46 
14. 14528 Trauma 4.76 
15. 14598 Trauma 3.88 
16. 14606 Trauma 4.28 
17. 14622 Trauma 3.98 
18. 14661 Trauma 4.44 
19. 14669 Trauma 3.96 
20. 14702 Trauma 3.16 
21.  14736 Trauma 4.42 
22. 14398 Smoking 3.08 
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23. 14410 Smoking 3.52 
24. 14704 Smoking 3.06 
25. 14707 Smoking 3.18 
 
SUB-GROUP IIIA : Etiology of maawa/gutka chewing 
SUB-GROUP IIIB : Etiology of trauma 
SUB-GROUP IIIC : Etiology of smoking 
 
Table 8: mAgNOR COUNTS IN GROUP IV – Carcinoma of RETROMOLAR 
TRIGONE AREA 
SNo HP No ETIOLOGY mAgNOR 
1. 14375 Betel quid chewing 3.44 
2. 14497 Betel quid chewing 3.44 
3. 14523 Betel quid chewing 2.70 
4. 14636 Betel quid chewing 2.23 
5. 14667 Betel quid chewing 2.63 
6. 14280 Maawa/gutka chewing 3.14 
7. 14288 Maawa/gutka chewing 3.46 
8. 14328 Maawa/gutka chewing 3.58 
9. 14395 Maawa/gutka chewing 3.14 
10. 14460 Maawa/gutka chewing 3.52 
11. 14461 Maawa/gutka chewing 3.56 
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12. 14563 Maawa/gutka chewing 3.88 
13. 14706 Maawa/gutka chewing 3.10 
14. 14441 Smoking 2.68 
15. 14446 Smoking 2.76 
 
SUB-GROUP IVA : Etiology of Betel quid chewing 
SUB-GROUP IVB : Etiology of Maawa/gutka chewing 
SUB-GROUP IVC : Etiology of smokin 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
Table 9:STATISTICAL ANALYSIS AND RESULTS; 
 Descriptive Statistics of the variables with Minimum,Maximum,Mean and 
Standard deviation 
 
Number  Minimum Maximum 
Mean 
mAgNOR 
count 
Standard 
Deviation 
GROUP I 30 2.26 4.32 3.1883 .48834 
GROUP II 24 2.22 3.75 3.1350 .41558 
GROUP III 25 2.58 4.76 3.6724 .62120 
GROUP IV 15 2.23 3.88 3.1507 .46153 
SGIA 8 2.55 3.87 2.9975 .49511 
SGIB 15 2.26 4.32 3.0960 .49812 
SGIC 7 3.32 3.68 3.6043 .12634 
SGIIA 13 2.22 3.58 2.9562 .44077 
SGIIB 6 3.12 3.75 3.3783 .20856 
SGIIC 5 2.75 3.64 3.3080 .35450 
SGIIIA 8 2.58 3.86 3.1375 .41258 
SGIIIB 13 3.16 4.76 4.1438 .39790 
SGIIIC 4 3.06 3.52 3.2100 .21323 
SGIVA 5 2.23 3.44 2.8880 .53486 
SGIVB 8 3.10 3.88 3.4225 .27453 
SGIVC 2 2.68 2.76 2.7200 .05657 
 
  SG – Sub-Group 
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Table 10: COMPARISON OF MEAN AgNOR COUNT BETWEEN THE 
STUDY GROUPS 
   The mean value of AgNOR count for four groups were compared by one way 
analysis of variance (ANOVA) 
ANOVA between the groups 
  Mean 
Standard 
Deviation 
F value 
 
P value 
 
GROUP  I 3.1883 .48834 
6.262 .001 
GROUP II 3.1350 .41558 
GROUP III 3.6724 .62120 
GROUP IV 3.1507 .46153 
      
INFERENCE : 
  The results indicate P value equal to 0.001. There is significant difference 
between groups (P<0.05) with respect to mean AgNOR counts. 
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Table 11: MULTIPLE COMPARISON OF MEAN AgNOR COUNTS 
BETWEEN STUDY GROUPS 
  Multiple comparisons are made between different study groups for significant 
difference in the mean AgNOR counts. 
Multiple Comparisons 
GROUP I, GROUP II, GROUP III, GROUP IV 
Tukey HSD PROCEDURE 
(I)  
GROUP
S 
(J)  
GROUPS 
Mean 
Difference  
(I-J) 
Standard 
Error 
P value 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
GROUP 
I 
GROUP II .05333 .13884 .981 -.3101 .4168 
GROUP III -.48407 .13729 .004 -.8434 -.1247 
GROUP IV .03767 .16032 .995 -.3820 .4573 
GROUP 
II 
GROUP I -.05333 .13884 .981 -.4168 .3101 
GROUP III -.53740 .14488 .002 -.9166 -.1582 
GROUP IV -.01567 .16686 1.000 -.4525 .4211 
GROUP 
III 
GROUP I .48407 .13729 .004 .1247 .8434 
GROUP II .53740 .14488 .002 .1582 .9166 
GROUP IV .52173 .16558 .012 .0883 .9552 
GROUP 
IV 
GROUP I -.03767 .16032 .995 -.4573 .3820 
GROUP II .01567 .16686 1.000 -.4211 .4525 
GROUP III -.52173 .16558 .012 -.9552 -.0883 
 
INFERENCE: 
 The mean AgNOR counts of group III is significantly different from group I, 
II and III (P<0.05). Hence, the mean AgNOR counts for squamous cell carcinoma of 
tongue is significantly higher than the mean AgNOR counts in squamous cell 
carcinoma of other sites. 
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COMPARISON OF MEAN AgNOR COUNT BETWEEN THE SUB-GROUPS 
IN GROUP I 
Table 12: ANOVA between the Sub- groups of GROUP 1 
  Mean 
Standard 
Deviation F value P value 
SG IA 2.9975 .49511 
4.164 .027 SG IB 3.0960 .49812 
SG IC 3.6043 .12634 
SG – Sub-group 
 
Table 13: Multiple Comparisons between sub-groups of group I 
 
Turkey HSD procedure 
(I) 
SG I    
ABC 
(J) 
SG I 
ABC 
Mean 
Difference 
 (I-J) Std. Error P value 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
SG IA 
SG IB -.09850 .19370 .868 -.5788 .3818 
SG IC -.60679 .22899 .034 -1.1745 -.0390 
SG IB 
SG IA .09850 .19370 .868 -.3818 .5788 
SG IC -.50829 .20252 .047 -1.0104 -.0061 
SG IC 
SG IA .60679 .22899 .034 .0390 1.1745 
SG IB .50829 .20252 .047 .0061 1.0104 
SG – Sub-group 
 
INFERENCE: 
The mean AgNOR counts for different sub-groups within Group I are 
compared using ANOVA and the P value of 0.027 denotes that the difference is 
statistically significant (P<0.05) 
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Multiple comparisons within sub-groups of group I by Turkey HSD showed 
significant difference in mean AgNOR counts between sub groups IA & IC , IB & IC  
(P<0.05) and difference between IA & IB is not significant. 
 The mean AgNOR counts for carcinoma of buccal mucosa with etiology of 
smoking significantly higher than those with etiology of betel quid chewing and 
maawa/gutka chewing. 
 
Table 14: COMPARISON OF MEAN AgNOR COUNT BETWEEN THE SUB-
GROUPS IN GROUP II 
ANOVA between the Sub- groups in Group II 
  
Mean Std. Deviation 
F valve P value 
SG IIA 2.9562 .44077 
3.168 0.06* SG IIB 3.3783 .20856 
SG IIC 3.3080 .35450 
* Not Significant 
SG – Sub Group 
INFERENCE: 
 There is no significant difference in the mean AgNOR values between 
different sub-groups in group II. (P>0.05) 
 There is no significant difference in mean AgNOR counts in Carcinoma of 
alveolar mucosa due to different etiologies. 
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COMPARISON OF MEAN AgNOR COUNT BETWEEN THE SUB-GROUPS 
IN GROUP III 
Table 15 :ANOVA between the Sub- groups in Group III 
  
Mean 
Standard  
Deviation 
F value P value 
SG IIIA 3.1375 .41258 
20.561 .000 SG IIIB 4.1438 .39790 
SG IIIC 3.2100 .21323 
SG- Sub Group 
 
Table 16: Multiple Comparisons between Sub-groups in Group III 
Group III 
Tukey HSD 
(I) 
 SG III 
ABC 
(J) 
 SG III 
ABC 
Mean 
Difference  
(I-J) Std. Error Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
SG IIIA 
SG IIIB -1.00635 .17212 .000 -1.4387 -.5740 
SG IIIC -.07250 .23456 .949 -.6617 .5167 
SG IIIB 
SG IIIA 1.00635 .17212 .000 .5740 1.4387 
SG IIIC .93385 .21901 .001 .3837 1.4840 
SG IIIC 
SG IIIA .07250 .23456 .949 -.5167 .6617 
SG IIIB -.93385 .21901 .001 -1.4840 -.3837 
SG- Sub Group 
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INFERENCE : 
The mean AgNOR counts for different sub-groups within Group III are 
compared using ANOVA and the P value of 0.000 denotes that the difference is 
statistically significant (P<0.05) 
Multiple comparison between the groups using Turkey HSD procedure shows 
the difference in mean AgNOR count between 3A & 3C is not significant but IIIA & 
IIIB (P = 0.000), IIIB & IIIC (P= 0.001) are significantly different (P<0.05). 
In Carcinoma of tongue, cases with trauma as the etiological factor show 
significantly higher mean AgNOR counts when compared to cases with smoking or 
betel quid chewing habit. 
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Table 17:COMPARISON OF MEAN AgNOR COUNT BETWEEN THE SUB-
GROUPS IN GROUP IV 
ANOVA between the Sub- groups in Group IV 
  Mean Std. Deviation F value Sig. 
SG IVA 2.8880 .53486 
4.682 .066 SG IVB 3.4225 .27453 
SG IVC 2.7200 .05657 
SG – Sub Group 
INFERENCE: 
There is no significant difference in the mean AgNOR values between 
different sub-groups in group IV. (P value >0.05) 
 There is no significant difference in mean AgNOR counts in Carcinoma of 
retromolar trigone region due to different etiologies. 
 
 
Table 18: Comparison of mean AgNOR counts between groups in patients with 
Betel quid chewing habit 
ANOVA between the Sub- groups- IA IIA IVA 
  Mean Std. Deviation F Sig. 
SG IA 2.9975 .49511 
.082 0.921* SG IIA 2.9562 .44077 
SG IVA 2.8880 .53486 
* Not Significant 
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INFERENCE : 
 There is no significant difference in the mean AgNOR counts between the 
sub-groups IA, IIA, IVA. (P value >0.05) 
 There is no significant difference in the cell proliferation rate in oral squamous 
cell carcinoma of buccal mucosa, alveolar mucosa and retromolar area among 
betelquid chewers. 
 
Table 19: Comparison of mean AgNOR counts between groups in patients with 
maawa/gutka habit 
ANOVA between the Sub- groups- IB IIB IIIA IVB 
  Mean Std. Deviation 
F Sig. 
SG IB 3.0960 .49812 
1.552 .219 
SG IIB 3.3783 .20856 
SG IIIA 3.1375 .41258 
SG IVB 3.4225 .27453 
* Not Significant 
 
INFERENCE: 
There is no significant difference in the mean AgNOR counts between the 
sub-groups IIA, IIB, IIIA and IVB. (P value >0.05) 
 There is no significant difference in the cell proliferation rate in oral squamous 
cell carcinoma of buccal mucosa, alveolar mucosa, tongue and retromolar area among 
maawa or gutka chewers. 
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GRAPHICAL REPRESENTATION OF RESULTS 
Fig 9. Comparison of mAgNOR counts between the four groups (P<0.05) 
 
 
Fig 10. Comparison of mAgNOR counts in Group I sub-groups (P<0.05) 
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Fig 11. Comparison of mAgNOR counts in Group II sub-groups (P>0.05) (not 
significant) 
 
 
Fig 12. Comparison of mAgNOR counts in Group III sub-groups (P<0.05) 
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Fig 13. Comparison of mAgNOR couns in Group IV sub-groups (P>0.05) (not 
significant) 
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DISCUSSION 
Oral squamous cell carcinoma (OSCC) is associated with increasing mortality 
rates in India.
2
  The prognosis of oral cancer depends on many clinicopathological 
parameters including site of origin and etiolological factors which has been supported 
by studies by Shiu S et al,
48
 2004, Garzino-Demo P,
17
 et al 2006, Subapriya R et 
al,
49
 2007, etc,. Cell proliferation rate has been considered as one of the determinants 
of prognosis in oral cancer.
24
 In this study, we have evaluated the cell proliferation 
rate in some of the common subsites of OSCC and also studied the influence of some 
of the etiological factors on cell proliferation rate in different subsites of OSCC and 
therefore indirectly determining the prognostic implication of variation in subsites and 
etiologies of oral cancer. 
 There are many methods to determine the cell proliferation rate.
4,25
 However 
in this study we used quantification of silver-stained nucleolar organizer regions, as it 
is cheaper, reliable, less time consuming method and also the results obtained are 
comparable to other proliferative markers which are determined by complex 
procedures.
12
 The expression of AgNOR protein is especially associated with rapidity 
of cell proliferation and a higher AgNOR count is associated with aggressive 
phenotype. There are many studies involving AgNORs as cell proliferation marker in 
oral cancer. 
11,32,37,38
 A standardized method for AgNOR quantification is available 
and it produced reproducible results.
30 
 In this present study we included 94 cases of oral squamous cell carcinoma 
involving buccal mucosa, alveolus, tongue and retromolar trigone area. The 
commonest site invoved was buccal mucosa followed by almost equal number of 
cases with carcinoma of tongue and alveolus. The predominance in the involvement 
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of buccal mucosa is in accordance with studies conducted by Kaur J et al,
40
 1994, 
Manu V et al,
50
 2006 .
 
 According to studies conducted by Garzino-Demo P et al,
17
 2006, Rusthoven 
K et al,
18
 2008 there is difference in prognosis for different subsites of oral carcinoma. 
Ratuva et al,
51
 2007
 
have attributed the difference in prognosis to the type of oral 
epithelium – keratinized, non keratinized and specialized mucosa, as these were found 
to have different turnover rates and the keratin layer acts as a barrier to outside 
environment. None of these studies compared the cell proliferation rate as a cause for 
difference in prognosis for these sub-sites. However, in this study we found a 
significant difference in cell proliferation rate for carcinoma of buccal mucosa, 
alveolus, tongue and retromolar trigone area as shown by the significant difference in 
the mean AgNOR counts for these subsites.  
 Carcinoma of tongue showed significantly higher mean AgNOR counts when 
compared to other subsites. This correlates with the poor prognosis of tongue cancer 
as established by studies by Garzino-Demo P et al,
17
 in 2006, Rusthoven K et al,
18
 in 
2008. Further studies are required  comparing the cell proliferation in different 
subsites and to establish  difference in cell proliferation rate as a cause for difference 
in prognosis among different subsites. 
 Various etilogical factors have been considered to influence the prognosis of 
oral squamous cell carcinoma. Various studies included betel quid chewing, 
mawa/gutka chewing, snuff dipping, smoking and alcohol as the chief etiological 
factors.
40-47
The previous demographic data collected from patients in our department 
suggested that cases of oral squamous cell carcinoma reporting to our department had 
the habits of betel quid chewing with tobacco, maawa or gutka chewing, smoking and 
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use of oral snuff. Since there were very few cases with etiology of using oral snuff 
during the period of our study, comparable results couldn’t be obtained and hence 
eliminated from our study. Although alcohol is considered as the etiological factor in 
many of the studies in literature, use of alcohol alone does not cause cell proliferation 
per se and it acts synergistically when combined with the habit of smoking or 
chewing.
41,44
 Alcohol acts as a solvent for many carcinogens including tobacco 
carcinogens, thereby enhancing tissue penetration.
50
 During our study period none of 
the patients reported had OSCC and habit of alcoholism alone.  The patients who had 
chronic alcoholism along with other etilological factors included in our study were 
eliminated. 
 Another common etiological factor that we come across in cases reporting to 
our department with squamous cell carcinoma of tongue is trauma. Although it is said 
that chronic irritation to oral mucosa by the contents of quid is a source of trauma and 
causes oral cancer, there are a few number of studies, as revealed by pubmed search, 
considering trauma as one of the etiological factor for oral cancer.
52,53,54
 In our study, 
mean AgNOR counts in squamous cell carcinoma of tongue due to trauma was 
significantly higher as compared to other etiological factors. Hence trauma should be 
considered in studies conducted on tongue cancer as it may have a prognostic 
implication. 
 In this study, there was no significant difference in mean AgNOR counts due 
to etiologies in other subsites except in carcinoma of buccal mucosa where smoking 
showed greater cell proliferation index when compared to other etiologies. But studies 
conducted by Znaor A et al,
42
 2003 and Lin WJ et al,
44
 2011 showed betel quid 
chewing to have highest risk when compared to smoking in oral cavity, but cell 
proliferation or prognosis was not considered in either of the studies. 
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 Thus, among the four subsites considered in this study, squamous cell 
carcinoma of tongue showed significantly higher cell proliferation rate which explains 
its poor prognosis and trauma is one of the often neglected but chief etiological factor 
for tongue cancer as it causes greater cell proliferation when compared to other 
etiologies. Further studies are implicated to associate higher cell proliferation rate to 
poor prognosis in tongue squamous cell carcinoma and also considering trauma as one 
of the chief etiological factor. 
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SUMMARY AND CONCLUSION 
AgNORs are considered to be important cell proliferation marker and a 
predictor of prognosis in OSCC. The higher the cell proliferation rate, higher is the 
mean AgNOR count and poorer is the prognosis. 
In the present study, we have included 94 patients with OSCC and compared 
the cell proliferation rate by mean AgNOR counts in some of the common subsites of 
OSCC and also studied the influence of the etiological factors on cell proliferation 
rate which in turn reflects the prognosis in different subsites of OSCC. Of the four 
subsites included OSCC of tongue showed significantly higher mean AgNOR counts 
when compared to OSCC of buccal mucosa, alveolar mucosa and retromolar trigone 
area (P<0.05) and in OSCC of tongue, trauma showed significantly greater mean 
AgNOR counts when compared to other etiological factors. Similarly in OSCC of 
buccal mucosa smoking showed greater mean AgNOR counts when compared to 
other etiological factors (P<0.05). 
From the results of this study the following conclusion can be drawn: 
1. OSCC of tongue shows greater cell proliferation rate and thus correlating with its 
poorer prognosis as established by many other studies. 
2. Trauma causes significantly higher cell proliferation in OSCC of tongue and hence 
should be considered as one of the important prognostic determinant in further studies 
involving OSCC of tongue. 
 Further studies are required implicating the difference in cell proliferation rate 
due to different etiological factors in OSCC sub-sites to establish conclusive results. 
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Appendix 1 
INFORMATION SHEET 
 
 We are conducting a study on “CELL PROLIFERATION IN ORAL 
SQUAMOUS CELL CARCINOMA IN DIFFERENT SUBSITES”. 
For that study, we are selecting patients. 
 The purpose of this study is to compare the cell proliferative index and to 
evaluate the role of causative factors among different sub sites within the 
oral cavity. 
 The identity of the patients participating in the research will be kept 
confidential throughout the study. In the event of any publication or 
presentation resulting from the research, no personally identifiable 
information will be shared. 
 Taking part in the study is voluntary. You are free to decide whether to 
participate in the study or to withdraw at any time; your decision will not 
result in any loss of benefits to which you are otherwise entitled. 
 The results of the special study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which may 
aid in the management or treatment. 
 
 
 
Name of the patient                 Signature / Thumb impression
  
 
 
 
 
Name of the investigator        Signature       Date 
 
 
Appendix 2 
INFORMED CONSENT FORM 
 
 
STUDY TITLE: 
 
“CELL PROLIFERATION IN ORAL SQUAMOUS CELL CARCINOMA IN 
DIFFERENT SUBSITES”, 
  
 
Name:                 O.P.No:               H/P no:           
 
Address:                S. No:               Group no: 
 
                 Age / Sex:  
        
                 Tel. no: 
 
I, _____________________________________________________ age ________ years 
exercising my free power of choice, hereby give my consent to be included as a 
participant in the study “CELL PROLIFERATION IN ORAL SQUAMOUS CELL 
CARCINOMA IN DIFFERENT SUBSITES” 
 
I agree to the following: 
  
 I have been informed to my satisfaction about the purpose of the study and study 
procedures including investigations to monitor and safeguard my body function. 
 I have been informed that the biopsy tissue specimen taken for diagnosis purpose 
will only be used for the study and no other extra tissue specimen will be taken 
from me for the purpose of study. 
 I agree to share details of my personal habits for the purpose of the study and I 
am told that the investigating doctor and institution will keep my identity 
confidential. 
 I hereby give permission to use my medical records for research purpose. I am 
told that the medical details will also be kept confidential. 
 
 
 
Name of the patient   Signature / Thumb impression  
 
 
Name of the investigator  Signature       Date 
x¥òjš got« 
MuhŒ¢áÆ‹ jiy¥ò 
thÆš tU« thŒ ïW¡FnehŒ, thŒò‰WnehŒ k‰W« neha‰w eg®fË‹ 
FUâ CÚÇš cŸs Õ£lh - fnuh£oÅ‹ msit m¿í« MuhŒ¢á 
bga®  :     òw nehahË v©: 
KftÇ :     v© : 
taJ/ ghš: 
 
bjhiyngá v© :       
eh‹ ........................................ taJ .............. tUl«  
vdJ KGkdJl‹ thÆš tU« “thŒ ïW¡FnehŒ, thŒò‰WnehŒ 
k‰W« neha‰w eg®fË‹ FUâ CÚÇš cŸs Õ£lh - fnuh£oÅ‹ msit 
m¿í«  MuhŒ¢á”Æš g§F bgw r«kâ¡»nw‹. 
eh‹ Ñœf©lt‰W¡F r«kâ¡»nw‹ 
 eh‹ ïªj MuhŒ¢áÆ‹ neh¡f« k‰W« MuhŒ¢áÆ‹ KiwfŸ g‰¿ 
KGikahf bjÇÉ¡f¥g£LŸns‹. 
 eh‹ v‹ FUâ CÚiu MuhŒ¢á¡F¥ ga‹gL¤j x¥òjš mË¡»nw‹. 
 eh‹ v‹Dila kU¤JtU¡F KG x¤JiH¥ò ju r«kâ¡»nw‹. eh‹ 
VnjD« clš mbrsfÇa« V‰g£lhš kU¤JtÇl« cldoahf¤ 
bjÇÉ¥ng‹. 
 eh‹ kU¤JtÇl« ïj‰F K‹d® k‰W« j‰nghJ c£bfhŸS« 
kUªJfŸ g‰¿í«, vd¡F cŸs k‰w ÉahâfŸ g‰¿í« KGikahf¤ 
bjÇÉ¥ng‹ 
 eh‹ MuhŒ¢áÆ‹ j‹ik¡nf‰g njit¥gL« neu¤âš kU¤Jtiu¤ 
bjhl®ò¡ bfhŸnt‹. 
 eh‹ v‹ kU¤Jt¥ got§fis MuhŒ¢á¡fhf cgnahf¥ gL¤j 
mDkâ¡»nw‹. eh‹ kU¤Jt® k‰W« kU¤Jtkid v‹Dila 
milahs¤ij ufáakhf it¥gh®fŸ v‹W Tw¥g£LŸns‹. 
 
 
................................ 
nehahËÆ‹ bga® 
................................ 
ifbah¥g«/ifnuif
................................ 
njâ 
   
................................ 
MuhŒ¢áahsÇ‹ bga® 
................................ 
ifbah¥g« 
................................ 
njâ 
MuhŒ¢á g‰¿a jftš got« 
1. thÆš tU« “thŒ ïW¡FnehŒ, thŒò‰WnehŒ k‰W« neha‰w 
eg®fË‹ FUâ CÚÇš cŸs Õ£lh - fnuh£oÅ‹” msit m¿jš 
F¿¤J MuhŒ¢á brŒí« bghU£L jÄœehL muR gš kU¤Jtkid 
k‰W« fšÿÇ¡F tU« nehahËfŸ nj®î brŒa¥gL»wh®fŸ. 
2. ïªj MuhŒ¢áÆ‹ neh¡f« thÆš tU« “thŒ ïW¡FnehŒ, 
thŒò‰WnehŒ k‰W« neha‰w eg®fË‹ FUâ CÚÇš cŸs  
Õ£lh - fnuh£oÅ‹” msit m¿jš MF«. 
3. nehahË g‰¿a F¿¥òfŸ ãw® m¿aht©z« MuhŒ¢á 
Koí«tiu ïufáakhf ghJfh¡f¥gL«. mij btËÆL« neu¤âš 
vªj nehahËÆ‹ jÅ milahs§fS« btËÆl thŒ¥ò »ilahJ. 
4. ïªj MuhŒ¢áÆš ï§F bgWtJ nehahËÆ‹ jÅ¥g£l Koî 
k‰W« nehahËfŸ ïªj MuhŒ¢áÆš ïUªJ v¥bghGJ 
nt©LkhdhY« Éy»¡ bfhŸsyh«. nehahËÆ‹ ïªj ÔO® Koî, 
mtU¡nfh mšyJ MuhŒ¢áahsU¡nfh vªjÉj ghâ¥ò« 
V‰gL¤jhJ v‹gij bjÇa¥ gL¤J»nwh«. 
5. ïªj MuhŒ¢áÆ‹ KoîfŸ nehahËfS¡F MuhŒ¢á Koí« 
jWthÆnyh mšyJ ïilÆnyh bjÇÉ¡f¥gL«. MuhŒ¢áÆ‹bghGJ 
VJ« ã‹ ÉisîfŸ V‰g£lhš mij rÇ brŒa jFªj cjÉfŸ 
mšyJ njitahd á»¢irfŸ cldoahf nk‰bfhŸs¥gL«. 
 
 
nehahËÆ‹ bga®: ifbah¥g«/ifnuif 
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Appendix 3 : To determine mean AgNOR counts in 100 cells 
S.NO    :                                                                                                          GROUP : 
HP NO :                                                                                                    ETIOLOGY : 
 
          
          
          
          
          
          
          
          
          
          
 
                                                                                     mAgNOR count : 
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APPENDIX IV – COMMENTS AND SUGGESTIONS BY SUPERVISOR 
.  
 
Comment 
1.  
1.      Principal should be acknowledged 
first, followed by dissertation screening 
committee and ethical committee, and 
then proceed with acknowledging the 
rest. 
2.      Remove the word ‘guide’ where 
ever necessary and replace with just 
‘supervisor’ 
3.     I thank Dr. I. Ponniah for his help 
in the dissertation and overall guidance 
during my MDS course. 
4.      I am not the principal investigator. 
5.      In the declaration by the student, 
state firmly that I (Dr. Arya.A.N) is 
entirely responsible for any ethical 
violations (if any) and it does not have 
any binding on my supervisor. 
  Corrections made as 
suggested 
 
 
 Changed ‘guide’ to 
‘supervisor’ 
 
Corrections made 
 
Principal investigator 
changed to co-investigator 
 
 Separate declaration by 
candidate enclosed 
accordingly 
Comment 2a In the abstract section, include aim and 
objective(s). 
 Objective added 
 
SUGGESTIONS FOR OTHER SECTIONS - NIL 
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APPENDIX - V 
HISTORY AND PRE-HISTORY OF DISSERTATION 
Whether a course in research methodology was 
attended? 
Yes,  from 31-01-2012 to              
04-02-2012 
Whether adequate training obtained before starting 
dissertation with regard to conception, design and 
literature search?  
Yes, it was given in the first year of 
MDS course. 
When was the dissertation topic selected? 13-11-2012 
Whether topic selection was discussed with the guide? Yes 
Whether a research question put forth? Yes 
Whether aim and objective was discussed and got 
approved from the guide? 
Yes,  25-11-2012 
Whether materials and methods discussed and got 
approved? 
Yes, 05-12-2012 
Whether the topic got approved from the dissertation 
screening and ethical committees? 
Yes, 25-01-2012 
Whether the study protocol differed from that initially 
conceived and approved by the ethical committee? If 
yes, state the reasons. 
Number of cases were increased as 
there weren’t adequate number of 
cases for comparison in certain sub 
groups 
Whether the data for review of literature discussed 
with the guide? 
No. 
Whether literature review was shown to the guide, and 
if yes, when it was shown? 
YES on 26-12-2012 
Who did data analysis and interpretation? I did data analysis and interpretation. 
Who did statistical analysis and when it was 
completed? 
STATISTICIAN on  5-12-2012 
Whether bibliography discussed with the guide? No. 
Whether printed copy of bibliographies provided to the 
guide? 
Yes 
When was the following textual content shown to the 
guide? When was returned to you after correction? 
Whether the following were approved on initial 
submission or required number of corrections? 
 
 
 
 
(i) Introduction 27-08-2012 (2 corrections) 
(ii) Aim and Objective 25-11-2012 (2 corrections) 
(iii) Review of Literature 26-12-2012 
(iv) Material and Methods 05-12-2012 (2 corrections) 
(v) Results 26-12-2012 
(vi) Discussion 26-12-2012 
(vii) Conclusion 26-12-2012 
(viii) Bibliography  26-12-2012 
Whether the above sections were edited for language 
and intellectual content? 
 
Whether the final document was checked for overlap 
with previous work by others? 
Only for introduction 
 
 
No 
When was it shown and got approved? shown on 26-12-2012 at 11.30 am 
and got approved at 11.50 am 
Whether answer was found to the research question? YES 
 
